Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

A target trial emulation of the safety and efficacy of a deep learning system for individualising diabetic eye screening in the UK

Paul Nderitu; Nikhil Jain; Samantha Mann; Christos Bergeles; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):496.

ARVO Annual Meeting Abstract June 2025

NEON-NPDR study to investigate the efficacy and safety of the sGC-activator runcaciguat (RC) in patients with non-proliferative diabetic retinopathy

Kai Riecke; Neil M Bressler; Sobha Sivaprasad; Chan Ning Lee; Isabel Pires; Allen Hu; Jakob Grauslund; João Figueira; Desislava Koleva-Georgieva; Timothy L Jackson; Charles Clifton Wykoff; Tobias Niesen; Stefan Klein; Fabio Baschiera

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3310.

ARVO Annual Meeting Abstract June 2024

Validation of deep learning systems for predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy

Paul Nderitu; Joan M Nunez do Rio; Laura Webster; Samantha Mann; David Hopkins; M. Jorge Cardoso; Marc Modat; Christos Bergeles; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2768.

ARVO Annual Meeting Abstract June 2024

AutoMorph Optimization for Enhanced Retinal Vessel Analysis in Premature Infants

Gongyu Zhang; Bernardo Souza Mendes; Siegfried Wagner; Ana Paula Ribeiro Reis; Taha Soomro; Gunjan Naik; Pallavi Bagga; Rosana Lima; Hanna Faber; Hanna Faber; Dun Jack Fu; Christos Bergeles; Timothy L Jackson; Ismail Moghul; Nikolas Pontikos; Konstantinos Balaskas

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2396.

ARVO Annual Meeting Abstract June 2022

Efficacy and Safety of OPT-302 in combination with Ranibizumab for Polypoidal Choroidal Vasculopathy

Jason S Slakter; Hanna R. Coleman; Charles Clifton Wykoff; Clare Price; Megan E. Baldwin; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):382 – F0213.

ARVO Annual Meeting Abstract June 2022

Predicting progression to referable diabetic retinopathy from retinal images and screening data using deep learning

Paul Nderitu; Joan Nunez do Rio; Laura Webster; Samantha Mann; David Hopkins; Jorge Cardoso; Marc Modat; Christos Bergeles; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2087 – F0076.

ARVO Annual Meeting Abstract June 2021

Safety of multiple intravitreal injections of ocriplasmin in subjects with non–proliferative diabetic retinopathy (NPDR): Results of the CIRCLE study.

Mahi Muqit; Ramin Tadayoni; J Hamouz; Victor H Gonzalez; Javier Montero; David Scales; Geeta V Menon; Prema Abraham; Timothy L Jackson; Ivan Fiser; Petra Kozma-Wiebe

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1083.

ARVO Annual Meeting Abstract July 2018

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Laura Kuehlewein; Nicole Troelenberg; Krunoslav Stingl; Sebastian Schleehauf; Akos Kusnyerik; Helmut Sachs; Johann Roider; Timothy L Jackson; Robert E MacLaren; Caroline Chee; Barbara Wilhelm; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4561.

Retina November 2017

Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS Study

PDF

Benedicte Lescrauwaet; Luc Duchateau; Thomas Verstraeten; Timothy L. Jackson
TAGS: macular holes, oasis trial, ocriplasmin, vision, vitreomacular traction syndrome
Invest. Ophthalmol. Vis. Sci.. 2017; 58(13):5842-5848. https://doi.org/10.1167/iovs.17-22363

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Optical coherence tomography in patients with Alpha IMS subretinal implant

Laura Kuehlewein; Veronique Kitiratschky; Mariya Gosheva; Thomas Edwards; Robert E MacLaren; Akos Kusnyerik; Cristina Angelescu; Timothy L Jackson; Chen-Hsin Sun; Caroline Chee; Helmut G Sachs; Barbara Wilhelm; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4189.

ARVO Annual Meeting Abstract April 2014

Visual outcome in 26 blind retinitis pigmentosa patients after implantation of subretinal Alpha-IMS devices

Eberhart Zrenner; Karl-Ulrich Bartz-Schmidt; Caroline Chee; Florian Gekeler; Timothy L Jackson; Robert MacLaren; Janos Nemeth; Helmut Sachs; Katarina Stingl; David Wong; SUBRET Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5967.

Retina March 2013

Measuring the Effect of Pars Plana Vitrectomy on Vitreous Oxygenation Using Magnetic Resonance Imaging

PDF

Andrew R. H. Simpson; Nicholas G. Dowell; Timothy L. Jackson; Paul S. Tofts; Edward H. Hughes
TAGS: alveolar ventilation function, cell respiration, magnetic resonance imaging, poly(adp-ribose) polymerases, portugal, vitrectomy, vitreous body
Invest. Ophthalmol. Vis. Sci.. 2013; 54(3):2028-2034. https://doi.org/10.1167/iovs.12-11258

Physiology and Pharmacology December 2012

Positively Charged Amphiphilic Chitosan Derivative for the Transscleral Delivery of Rapamycin

PDF

Naba Elsaid; Timothy L. Jackson; Mirza Gunic; Satyanarayana Somavarapu
TAGS: chitosan, micelles, rapamycin, sclera
Invest. Ophthalmol. Vis. Sci.. 2012; 53(13):8105-8111. https://doi.org/10.1167/iovs.12-10717

ARVO Annual Meeting Abstract March 2012

Amphiphilic Chitosan Nanomicelles For The Topical Delivery Of Rapamycin

Satyanarayana Somavarapu; Zeeneh Elsaid; Mirza Gunic; Naba Elsaid; Timothy L. Jackson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):315.

ARVO Annual Meeting Abstract March 2012

A Stable Chitosan-coated Nanomicelle Combination Of Vitamin E-TPGS And Cholesterol-PEG For The Topical Administration And Scleral Retention Of Rapamycin

Naba Elsaid; Zeeneh Elsaid; Satyanarayana Somavarapu; Timothy L Jackson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):328.

ARVO Annual Meeting Abstract April 2011

Safety Testing of Epimacular Brachytherapy using Microperimetry

Robert Petrarca; Matthew Richardson; Jeffrey A. Nau; Timothy L. Jackson

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1680.

ARVO Annual Meeting Abstract April 2011

Translational Diffusion Of Ranibizumab As Measured By Fluorescence Recovery After Photobleaching (frap)

Nishanthan srikantha; Timothy L. Jackson; Klaus Suhling; James Levitt

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2325.

Retina November 2008

Scleral Hydraulic Conductivity and Macromolecular Diffusion in Patients with Uveal Effusion Syndrome

PDF

Timothy L. Jackson; Ali Hussain; Ana M. S. Morley; Paul M. Sullivan; Andrea Hodgetts; Austen El-Osta; Jost Hillenkamp; Stephen J. Charles; Richard Sheard; Tom H. Williamson; Anupma Kumar; D. Alistair H. Laidlaw; W. Hong Woon; Mark J. Costen; Andrew J. Luff; John Marshall
TAGS: diffusion, effusion, sclera, syndrome, uvea, surgical procedures, operative, dextran
Invest. Ophthalmol. Vis. Sci.. 2008; 49(11):5033-5040. https://doi.org/10.1167/iovs.08-1980

Includes: Supplemental Content

Physiology and Pharmacology September 2008

Human Transscleral Albumin Permeability and the Effect of Topographical Location and Donor Age

PDF

Owen A. Anderson; Timothy L. Jackson; Jasmin K. Singh; Ali A. Hussain; John Marshall
TAGS: albumins, donors, permeability, sclera
Invest. Ophthalmol. Vis. Sci.. 2008; 49(9):4041-4045. https://doi.org/10.1167/iovs.07-1660

Physiology and Pharmacology November 2006

Human Scleral Hydraulic Conductivity: Age-Related Changes, Topographical Variation, and Potential Scleral Outflow Facility

PDF

Timothy L. Jackson; Ali Hussain; Andrea Hodgetts; Ana M. S. Morley; Jost Hillenkamp; Paul M. Sullivan; John Marshall
TAGS: sclera
Invest. Ophthalmol. Vis. Sci.. 2006; 47(11):4942-4946. https://doi.org/10.1167/iovs.06-0362

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A target trial emulation of the safety and efficacy of a deep learning system for individualising diabetic eye screening in the UK

NEON-NPDR study to investigate the efficacy and safety of the sGC-activator runcaciguat (RC) in patients with non-proliferative diabetic retinopathy

Validation of deep learning systems for predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy

AutoMorph Optimization for Enhanced Retinal Vessel Analysis in Premature Infants

Efficacy and Safety of OPT-302 in combination with Ranibizumab for Polypoidal Choroidal Vasculopathy

Predicting progression to referable diabetic retinopathy from retinal images and screening data using deep learning

Safety of multiple intravitreal injections of ocriplasmin in subjects with non–proliferative diabetic retinopathy (NPDR): Results of the CIRCLE study.

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS Study

Optical coherence tomography in patients with Alpha IMS subretinal implant

Visual outcome in 26 blind retinitis pigmentosa patients after implantation of subretinal Alpha-IMS devices

Measuring the Effect of Pars Plana Vitrectomy on Vitreous Oxygenation Using Magnetic Resonance Imaging

Positively Charged Amphiphilic Chitosan Derivative for the Transscleral Delivery of Rapamycin

Amphiphilic Chitosan Nanomicelles For The Topical Delivery Of Rapamycin

A Stable Chitosan-coated Nanomicelle Combination Of Vitamin E-TPGS And Cholesterol-PEG For The Topical Administration And Scleral Retention Of Rapamycin

Safety Testing of Epimacular Brachytherapy using Microperimetry

Translational Diffusion Of Ranibizumab As Measured By Fluorescence Recovery After Photobleaching (frap)

Scleral Hydraulic Conductivity and Macromolecular Diffusion in Patients with Uveal Effusion Syndrome

Human Transscleral Albumin Permeability and the Effect of Topographical Location and Donor Age

Human Scleral Hydraulic Conductivity: Age-Related Changes, Topographical Variation, and Potential Scleral Outflow Facility

To View More...

You must be signed into an individual account to use this feature.